Darmiyan

Darmiyan is a pioneering company that specializes in the development of advanced medical AI and brain imaging software, specifically its flagship product, BrainSee. This software has recently received De Novo FDA approval, marking a significant milestone in its journey to enhance brain health screening and monitoring. Darmiyan's technology focuses on understanding the intricate space between brain cells, grading the health of this area to provide insights into the transition from normal health to neurodegenerative diseases, particularly Alzheimer's disease.

The core functionality of BrainSee…